Research ArticleOriginal Article
Open Access

Risk factor for 31-day unplanned readmission to hospital in patients with pulmonary tuberculosis in China

Jing Cao, Shengpeng Liu and Juhua Huang
Saudi Medical Journal September 2021, 42 (9) 1017-1023; DOI: https://doi.org/10.15537/smj.2021.42.9.20210281

References

  1. 1.↵
    World Health Organization. Global tuberculosis report 2020. (Updated 2020 October 15. Accessed 2020 October 22). Available from: https://www.who.int/publications/i/item/9789240013131
  2. 2.↵
    1. Yang T,
    2. Chen T,
    3. Che Y,
    4. Chen Q,
    5. Bo D.
    Factors associated with catastrophic total costs due to tuberculosis under a designated hospital service model: a cross-sectional study in China. BMC Public Health 2020; 20: 1009.
    OpenUrlPubMed
  3. 3.↵
    1. Cui X,
    2. Gao L,
    3. Cao B.
    The management of latent TB infection in China needs to explore a new approach suitable for high-burden countries. Chinese Journal of Antituberculosis 2020; 42: 390.
    OpenUrl
  4. 4.↵
    1. Duggal R,
    2. Zhang Y,
    3. Diana ML.
    The association between hospital ACO participation and readmission rates. J Healthc Manag 2018; 63: e100–e114.
    OpenUrl
  5. 5.↵
    1. Finlayson K,
    2. Chang AM,
    3. Courtney MD,
    4. Edwards HE,
    5. Parker AW,
    6. Hamilton K, et al.
    Transitional care interventions reduce unplanned hospital readmissions in high-risk older adults. BMC Health Serv Res 2018; 18: 956.
    OpenUrlPubMed
  6. 6.↵
    1. Daras LC,
    2. Deutsch A,
    3. Ingber MJ,
    4. Hefele JG,
    5. Perloff J.
    Inpatient rehabilitation facilities’ hospital readmission rates for medicare beneficiaries treated following a stroke. Top Stroke Rehabil 2021; 28: 61–71.
    OpenUrl
  7. 7.↵
    1. Lefèvre JH,
    2. Reboul-Marty J,
    3. de Vaugrigneuse S,
    4. Zeitoun JD.
    Readmissions after surgery: a french nationwide cross-sectional study of 1,686,602 procedures performed in 2010.World J Surg 2017; 41: 31–38.
    OpenUrl
  8. 8.↵
    1. Hoffman H,
    2. Protas M,
    3. Chin LS.
    A nationwide analysis of 30-day and 90-day readmissions after elective cerebral aneurysm clipping in the United States: causes, predictors, and trends. World Neurosurg 2019; 128: e873–e883.
    OpenUrl
  9. 9.↵
    1. Wang Xiaoying,
    2. Wang Xiaoxia,
    3. Song Ying
    . Study on unplanned readmission patients in stomatological hospital within 31 days. China Health Statistics 2017; 34: 293–295.
    OpenUrl
  10. 10.↵
    1. Njoku CM,
    2. Alqahtani JS,
    3. Wimmer BC,
    4. Peterson GM,
    5. Kinsman L,
    6. Hurst JR, et al.
    Risk factors and associated outcomes of hospital readmission in COPD: A systematic review. Respir Med 2020; 173: 105988.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Shamaei M,
    2. Samiei-Nejad M,
    3. Nadernejad M,
    4. Baghaei P.
    Risk factors for readmission to hospital in patients with tuberculosis in Tehran, Iran: three-year surveillance. Int J STD AIDS 2017; 28: 1169–1174.
    OpenUrl
  12. 12.↵
    1. Rørth R,
    2. Fosbol EL,
    3. Mogensen UM,
    4. Kragholm K,
    5. Numé AK,
    6. Gislason GH, et al.
    Employment status at time of first hospitalization for heart failure is associated with a higher risk of death and rehospitalization for heart failure. Eur J Heart Fail 2018; 20: 240–247.
    OpenUrl
  13. 13.↵
    1. Scaria E,
    2. Powell WR,
    3. Birstler J,
    4. Alagoz O,
    5. Shirley D,
    6. Kind AJH, et al.
    Neighborhood disadvantage and 30-day readmission risk following clostridioides difficile infection hospitalization. BMC Infect Dis 2020; 20: 762.
    OpenUrl
  14. 14.↵
    1. Silva TC,
    2. Matsuoka PDFS,
    3. Aquino DMC,
    4. Caldas AJM.
    Factors associated with tuberculosis retreatment in priority districts of Maranhão, Brazil. Cien Saude Colet 2017; 22: 4095–4104.
    OpenUrl
  15. 15.↵
    1. Qayed E,
    2. Muftah M.
    Frequency of hospital readmission and care fragmentation in gastroparesis: A nationwide analysis. World J Gastrointest Endosc 2018; 10: 200–209.
    OpenUrl
  16. 16.↵
    1. Anaam MS,
    2. Alrasheedy AA,
    3. Alsahali S,
    4. Alfadly SO,
    5. Aldhubhani AH.
    Rate and risk factors of recurrent tuberculosis in Yemen: a 5-year prospective study. Infect Dis (Lond) 2020; 52: 161–169.
    OpenUrl
  17. 17.↵
    1. Zhao F,
    2. Du X,
    3. Li T,
    4. Wang LX,
    5. Zhang H,
    6. Liu JJ, et al.
    Epidemic trend and prediction of tuberculosis in China based on WHO public database. Journal of Clinical Drug Therapy 2018: 16: 1–3.
    OpenUrl
  18. 18.↵
    1. Shen XB,
    2. Kang LL,
    3. Zhou YZ,
    4. Qu L,
    5. Si ZL.
    Comparison of tuberculosis incidence and molecular epidemiological characteristics between urban and rural areas in northern Guizhou. Practical Preventive Medicine 2019; 26: 321–323.
    OpenUrl
  19. 19.↵
    1. Cheng J,
    2. Sun YN,
    3. Zhang CY,
    4. Yu YL,
    5. Tang LH,
    6. Peng H, et al.
    Incidence and risk factors of tuberculosis among the elderly population in China: a prospective cohort study. Infect Dis Poverty 2020; 9: 13.
    OpenUrl
  20. 20.
    1. Tegegne BS,
    2. Mengesha MM,
    3. Teferra AA,
    4. Awoke MA,
    5. Habtewold TD.
    Association between diabetes mellitus and multi-drug-resistant tuberculosis: evidence from a systematic review and meta-analysis. Syst Rev 2018; 7: 161.
    OpenUrlCrossRef
  21. 21.↵
    1. Sürücüoğlu S.
    Seyahat ile ilişkili tüberküloz riski [Risk of travel associated tuberculosis]. Mikrobiyol Bul 2018; 52: 96–107.
    OpenUrl
  22. 22.↵
    1. Pradipta IS,
    2. Van’t Boveneind-Vrubleuskaya N,
    3. Akkerman OW,
    4. Alffenaar JC,
    5. Hak E.
    Treatment outcomes of drug-resistant tuberculosis in the Netherlands, 2005-2015. Antimicrob Resist Infect Control 2019; 8: 115.
    OpenUrl
  23. 23.↵
    1. Bhatt SP,
    2. Balte PP,
    3. Schwartz JE,
    4. Cassano PA,
    5. Couper D,
    6. Jacobs DR Jr., et al.
    Discriminative accuracy of FEV1:FVC thresholds for COPD-related hospitalization and mortality. JAMA 2019; 321: 2438–2447.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Yakar HI,
    2. Gunen H,
    3. Pehlivan E,
    4. Aydogan S.
    The role of tuberculosis in COPD. Int J Chron Obstruct Pulmon Dis 2017; 12: 323–329.
    OpenUrlPubMed
  25. 25.↵
    1. Tacconelli E,
    2. Carrara E,
    3. Savoldi A,
    4. Harbarth S,
    5. Mendelson M,
    6. Monnet DL, et al.
    Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis 2018; 18: 318–327.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Perriot J,
    2. Underner M,
    3. Peiffer G,
    4. Flaudias V.
    Stratégie et modalités d’aide à l’arrêt du tabac chez les fumeurs tuberculeux [Strategy and stopping smoking interventions in smokers with tuberculosis]. Rev Med Liege 2020; 75: 100–104.
    OpenUrl
  27. 27.↵
    1. Byrne AL,
    2. Marais BJ,
    3. Mitnick CD,
    4. Lecca L,
    5. Marks GB.
    Tuberculosis and chronic respiratory disease: a systematic review. Int J Infect Dis 2015; 32: 138–146.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Perriot J,
    2. Underner M,
    3. Peiffer G.
    Le tabagisme et l’aide à l’arrêt du tabac des patients atteints de tuberculose [Tobacco smoking and stopping smoking interventions in patients with TB]. Rev Pneumol Clin 2018; 74: 391–399.
    OpenUrl
  29. 29.↵
    1. Abdelbary BE,
    2. Garcia-Viveros M,
    3. Ramirez-Oropesa H,
    4. Rahbar MH,
    5. Restrepo BI.
    Predicting treatment failure, death and drug resistance using a computed risk score among newly diagnosed TB patients in Tamaulipas, Mexico. Epidemiol Infect 2017; 145: 3020–3034.
    OpenUrlPubMed
  30. 30.↵
    1. Bestrashniy JRBM,
    2. Nguyen VN,
    3. Nguyen TL,
    4. Pham TL,
    5. Nguyen TA,
    6. Pham DC, et al.
    Recurrence of tuberculosis among patients following treatment completion in eight provinces of Vietnam: A nested case-control study. Int J Infect Dis 2018; 74: 31–37.
    OpenUrl
  31. 31.↵
    1. Wu CW,
    2. Lan CC,
    3. Hsieh PC,
    4. Tzeng IS,
    5. Wu YK.
    Role of peripheral eosinophilia in acute exacerbation of chronic obstructive pulmonary disease. World J Clin Cases 2020 6; 8: 2727–2737.
    OpenUrl
  32. 32.↵
    1. Breyer-Kohansal R,
    2. Hartl S,
    3. Breyer MK,
    4. Schrott A,
    5. Studnicka M,
    6. Neunhäuserer D,
    7. Fülöp G,
    8. Burghuber OC.
    The European COPD audit: Adherence to guidelines, readmission risk and hospital care for acute exacerbations in Austria. Wien Klin Wochenschr 2019; 131: 97–103.
    OpenUrl
  33. 33.↵
    1. Sun W,
    2. Pan L,
    3. Zhang W.
    Risk factors for readmission of children hospitalized with acute asthma attacks in South China. J Asthma 2021; 58: 438–447.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords